SeraCare Life Sciences, Inc.

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Chemistry, Immunoassay
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • Contract Research Organization-CRO
  • Services
See more in Biomedtracker

Latest on SeraCare Life Sciences, Inc.

In Vivo

Deals Shaping The Medical Industry, March 2016

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc

In Vivo

Deals Shaping the Medical Industry, February 2016

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc

Medtech Insight

Medical Device Deals Update, August 2015

SOURCE: Strategic Transactions

Scrip

New Zealand’s PHARMAC Flip Flops On Decision To Fund Roche, Abbott Glucose Meters In Favor Of Sole Supplier

 
• By James Dunn

MELBOURNE, Australia – New Zealand’s Pharmaceutical Management Agency (PHARMAC) reversed an earlier decision to subsidize a Korean sole supplier of insulin pumps, and announced it would continue to fu